US Patent Issued to Zelarion Malta on June 23 for "Method of treating an immune-related disorder or disease associated with an organ or tissue transplant with a combination of an anti-CD2 antibody and a CTLA-4 co-stimulation blockade" (Swedish, American Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,661,399, issued on June 23, was assigned to Zelarion Malta Ltd. (Birkirkara, Malta).

"Method of treating an immune-related disorder or disease associated with an organ or tissue transplant with a combination of an anti-CD2 antibody and a CTLA-4 co-stimulation blockade" was invented by David Berglund (New York), Erik Berglund (New York), Felix Sellberg (Uppsala, Sweden) and Christian Binder (Stockholm).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are improved anti-CD2 antibodies and methods for their use in the treatment and/or prevention of chronic or acute disorders of the immune system. Also provided herein are methods for treating or...